Form 4 Filing for William Guyer at CORCEPT THERAPEUTICS INC

On June 2, 2026, William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), reported a series of transactions. Guyer acquired 20,000 shares of Common Stock under a 10b5-1 plan at a price of $21.65 per share, increasing his post-transaction holdings to 23,985 shares. This acquisition involved shares underlying unvested restricted stock awards. Concurrently, Guyer disposed of 20,000 shares of Common Stock at a weighted average price of $70.60 per share (ranging from $70.44 to $70.86), reducing his post-transaction holdings to 3,985 shares. Additionally, Guyer exercised a stock option to buy 20,000 shares of Common Stock at $0.00 per share, with the underlying shares now totaling 150,000. The option is fully exercisable with an expiration date of September 1, 2031. These transactions were executed under a 10b5-1 plan adopted on November 27, 2024.